baber/WOPTO huggingface dataset:
Patent CA-2853781-A1 (CA)
Inventor: GRECO PAOLO
IPC: F03B13/18
Filed: 2012-11-01
Abstract: Device (100) for conversion of mechanical energy from sea waves to electric energy, characterized by: - at least a float (101) and two rigid rods (102), (103), preferably anchored at one end to the seabed (108), and at the other end to the float (101) through flexible cables (106), (107); two respective masses (104), (105) keep the free ends of that rods (102), (103), constantly in traction condition pulled towards the sea bed (108); - at least a power generator (109), or other similar device suitable to convert and/or transmit energy, that is placed close to its respective hinge (110), (111), placed at the bottom parts of the rods (102), (103), so that the oscillatory motion of the float (101), following the waves level (112), causes a force with a vertical component that leads to a rotatory and oscillatory motion of the rods (102), (103), which are pivoted on its respective hinge (110), (111), and generates therefore electric energy by motion of gears of the same generator (109); the horizontal component of the force due to the float (101) oscillations is balanced by a system of counterweights, so that the same float (101) tends to place itself constantly on vertical line A-A'.
Patent CA-2854823-A1 (CA)
Inventor: SLOUGH JOHN THOMAS
IPC: F03H1/00
Filed: 2012-11-06
Abstract: Systems and methods establish a magnetically insulated fusion process. An exemplary embodiment establishes a Field Reversed Configuration (FRC) plasma, wherein the FRC plasma is a closed field, magnetically confined plasma; collapses a metal shell about the FRC plasma; and establishes a fusion reaction in response to collapsing the metal shell about the FRC plasma.
Patent CA-2855900-A1 (CA)
Inventor: EICHHORN TORSTEN
IPC: C08G59/40
Filed: 2012-11-14
Abstract: The invention relates to the use of bis- or multifunctional N,N'-(dimethyl) urons as curing agents for curing epoxy resin compositions in a controlled manner.
Patent CA-2859838-A1 (CA)
Title: Astragalus seed extract solution and its use for treating skin disorders and conditions
Inventor: ZHANG PING
IPC: A61Q19/00
Filed: 2012-12-21
Abstract: An aqueous Astragalus seed extract solution prepared by a method including soaking dried seeds of Astragalus seed in an aqueous solvent to form a suspension, boiling the suspension for at least 30 minutes, and filtering the suspension so as to obtain the Astragalus seed aqueous extract solution, the weight ratio of the dried seeds of Astragalus seed to the extract solution being 1:100 to 75:100.
Patent CA-2860665-A1 (CA)
Title: Methods of treating cancer
Inventor: WONG KWOK-KIN
IPC: A61K31/7088
Filed: 2013-01-04
Abstract: The present invention provides methods of treating cancer, particularly cancers that are null or have decreased expression or activity of the Lkbl gene. Also included are methods of identifying therapeutic targets for the treatment of cancer.
Patent CA-2861989-A1 (CA)
Inventor: TORGERSRUD RICHARD
IPC: G06Q90/00
Filed: 2014-09-05
Abstract: An exemplary embodiment provides for a computer-implemented method for processing a secure facility resident request. The method includes accepting a request type selection by the secure facility resident, providing a request form corresponding to the request type, accepting input for the request form and routing the request form to secure facility staff for review. The method additionally includes routing the request form back to the secure facility resident if further information is required and if the further information is required, accepting the further information from the secure facility resident.
Patent CA-2863235-A1 (CA)
Inventor: HECHT GIL
IPC: B23C5/10
Filed: 2012-12-13
Abstract: A cutting insert includes a first surface, a second surface and a peripheral surface extending therebetween, and an insert hole extending between the first and second surfaces and having a hole axis. A cross section of at least a portion of the insert hole taken perpendicular to the hole axis has an oval shape. The cutting insert also includes a mark provided on at least one of the first and second surfaces, indicating the orientation of the cross sectional oval shape of the at least a portion of the insert hole.
Patent CA-2863812-A1 (CA)
Title: Antiviral compound and cox-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib
Inventor: PRIDGEN WILLIAM L
IPC: A01N43/56
Filed: 2013-02-06
Abstract: The disclosure relates to methods of treating fibromyalgia, by administering a therapeutically-effective combination of an antiviral component and a COX-2 inhibitor component. The invention is further related to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound famciclovir and a therapeutically-effective amount of the COX-2 inhibitor celecoxib. The invention is also related to methods of treating functional somatic syndromes by administering a therapeutically-effective combination of famciclovir and celecoxib.
Patent CA-2869768-A1 (CA)
Inventor: BOE PHILIP ALLEN
IPC: C10G50/00
Filed: 2013-04-12
Abstract: La présente invention concerne des procédés et un système permettant d'obtenir des carbones à longue chaîne, lesdites méthodes comprenant généralement les étapes consistant à former un mélange de conversion constitué d'un alcool et d'une base, à ajouter ledit mélange de conversion à de l'huile (par exemple de l'huile à base de pétrole, du pétrole brut, de l'huile usagée, de l'huile de vidange et de l'huile pour moteur neuve) afin d'obtenir un mélange réactionnel, à ajouter un composé à haute teneur en nitrates au mélange réactionnel et à isoler les carbones à longue chaîne afin de les utiliser comme intrants dans d'autres traitements, par exemple pharmaceutiques et/ou pétrochimiques supplémentaires. Des opérations complémentaires de refroidissement et/ou de filtration peuvent être mises en uvre pour parachever et/ou optimiser la conversion de l'huile.
Patent CA-2869918-A1 (CA)
Title: Louver display panel system for multi-story building
Inventor: MELIC JONATHAN J
IPC: G09F19/22
Filed: 2013-04-26
Abstract: A louver display panel system comprising one or more display panels for receiving advertising or other material thereon, one or more support members to secure the display panels to a building, and at least one louver movement control means. The panels are rotationally secured and mounted to the support members and form a louver structure. The control means maintains the panels in a first position where they are in a plane generally parallel to the exterior face of the building until a wind load applied to the panels exceeds a pre-determined value, after which the control means permits the panels to at least partially rotate toward a second position that is generally parallel to the direction of the wind to reduce the wind load borne by the display panels. The control means returns the panels to their first position when the wind load drops below the pre-determined value.
Patent CA-2870779-A1 (CA)
Inventor: HUNDLEY WALTER ARTHUR JR
IPC: B64D33/10
Filed: 2014-11-13
Abstract: A surface heat exchanger is provided which utilizes forward and aft brackets to retain the heat exchanger in position. The surface heat exchanger includes a plurality of core cooling channels as well as fins which are disposed for air flow through the gas turbine engine. The brackets include a low-friction wear material as well as an isolator sheet which provides some spring force on the heat exchanger.
Patent CA-2873881-A1 (CA)
Inventor: FLEMING STEPHEN BRUCE
IPC: A61P17/02
Filed: 2013-05-17
Abstract: Viral VEGF and viral anti-inflammatory cytokine compositions, methods of treatment using them, and kits containing them for use in the promotion and/or improvement of wound healing and/or tissue repair, and for anti-scarring, anti-inflammatory, anti-fibrosis and anti-adhesion indications.
Patent CA-2875284-A1 (CA)
Inventor: CARLYON JAMES L
IPC: A61M25/06
Filed: 2007-09-28
Abstract: Featured is a medical infusion device for vascular access with enhanced flashback visualization that includes a hub assembly having a flashback chamber. The hub assembly includes a proximal portion, a distal portion and a substantially transparent window section intermediate the proximal portion and distal portion. A needle is coupled to the flashback chamber so that fluid flows through the lumen of the needle into the flashback chamber after the needle is inserted into a blood vessel. A contrasting member is disposed on at least a portion of the hub assembly, so that when blood enters the flashback chamber, the contrasting member provides a high-contrast background when viewed through the window section.
Patent CA-2876124-A1 (CA)
Inventor: RYAN KATE M
IPC: E21B43/24
Filed: 2013-06-07
Abstract: Methods and systems relate to recovering hydrocarbons with an injection well placed at a bottom of a reservoir some horizontal distance from a producer, such that the injection well and producer may both be in a common horizontal plane. For some embodiments, the process includes co-injection of steam with a non-condensable gas, such as methane, ethane, propane, carbon dioxide, combustion products and combinations thereof. The non-condensable gas provides additional solution gas drive while the location of the injection well beside, instead of above, the producer increases production time before a steam chamber reaches a top of the reservoir, increasing thermal and recovery efficiency of the process.
Patent CA-2876255-A1 (CA)
Title: Procede pour fabriquer une composition de lactoserum modifie, composition de lactoserum modifie et procede pour fabriquer une composition de lactoserum modifie enrichie en calcium
Inventor: ODAKA MIREI
IPC: A23C21/00
Filed: 2013-06-14
Abstract: La présente invention concerne la fabrication d'une composition de lactosérum modifié, ledit procédé comprenant une étape de préparation de solution pour préparer une solution de départ contenant du lactosérum en utilisant une composition de lactosérum contenant une protéine de lactosérum et une étape de chauffage pour chauffer la solution de départ contenant du lactosérum, l'étape de préparation de solution impliquant un traitement consistant à ajouter un alcali dans la composition de lactosérum ; la valeur de pH de la solution de départ contenant du lactosérum est 6,8 à 8,0 et la concentration de protéine dans la solution est de 1,3 % massiques ou moins ; la solution de départ contenant du lactosérum devant être chauffée présente une teneur en calcium de 400 à 700 mg/100 g de matières solides ; et le traitement par chauffage est réalisé à 80-150 °C pendant 1 seconde à 30 minutes.
Patent CA-2876865-A1 (CA)
Inventor: LOUSHIN MICHAEL K H
IPC: A61F11/00
Filed: 2013-06-11
Abstract: An insertion system (200, 200') includes a handle assembly (205, 205') and a nose assembly (203, 203') removably attached to the handle assembly and including an insertion end (202, 202'). The handle assembly includes a main body (263, 263'), a nose interface (217, 217') and an actuating element (210, 210'). The nose assembly includes a nose (213, 213'), a positioning rod (204, 204') extending from the nose to a distal end (207), a cutting sheath (206, 206') surrounding the distal end of the positioning rod and including a cutting edge (209), an actuation member (214) having a proximal end coupled to the actuating element when the nose assembly is attached to the handle assembly and a distal end (221) attached to the cutting sheath. A ventilation tube (215) is positioned distal to the distal end of the positioning rod and proximal to the insertion end. The cutting sheath retracts from around the ventilation tube and along the positioning rod when the actuating element on the handle assembly is moved.
Patent CA-2877616-A1 (CA)
Inventor: FORD JOHN P
IPC: A61B5/055
Filed: 2013-06-24
Abstract: Systems and methods detect electrical activity in the human brain in the form of the generated magnetic fields and map the magnetic field strength to the surface of the cerebral cortex. By mapping the measured magnetic fields to the sulcal-defined gyrus of the cerebral cortex rather than to its three-dimensional volume, the data complexity and the resulting image are dramatically reduced. The device allows an inventory of brain function, including, but not limited to, vision, sound, sensory, and cognition, with the sensors placed over the corresponding region or regions of interest of the brain.
Patent CA-2881315-A1 (CA)
Inventor: RONCHI DANIEL MATTHEW
IPC: A61B5/11
Filed: 2013-07-24
Abstract: Apparatus is disclosed for monitoring, measuring and/or estimating a force applied to a body or body part of a vertebral mammal. The apparatus includes an acceleration sensor for measuring acceleration of the body or body part relative to an inertial frame of reference and for providing data indicative of the acceleration. The acceleration sensor includes at least one inertial sensor, a memory device adapted for storing the data, and a processor adapted for processing the data to evaluate a reaction force that correlates to the data. The processor may be configured to execute an algorithm for evaluating the reaction force, based on one or more correlation components such as mass, speed and/or velocity associated with the body or body part. A method of monitoring and/or estimating a force applied to a body or body part of a vertebral mammal is also disclosed.
Patent CA-2882458-A1 (CA)
Inventor: MULLER-SIEBERT REINHARD
IPC: B02C19/18
Filed: 2012-08-24
Abstract: The invention relates to a method for fragmenting and/or weakening material by means of high-voltage pulses, the material and a processing fluid being arranged in a processing zone formed between two electrodes such that the entire processing zone is flooded with processing fluid, and high-voltage pulses being applied to the electrodes such that high-voltage breakdowns occur between the two electrodes and/or such that predischarge channels are formed without breakdowns. An electrode with a metallic conductor (1) is chosen for at least one of the two electrodes, the conductor being provided partially or completely with an insulator or insulating coating (2) at the working end of the electrode that is in contact with the processing fluid, the permittivity of the insulator/insulating coating being at least 75% of the permittivity of the processing fluid. The use of such an electrode allows the energy efficiency of methods for fragmenting and/or weakening material by means of high-voltage pulses to be significantly improved and further allows greater tolerance to be achieved with respect to an increase in the conductivity of the processing fluid.
Patent CA-2884022-A1 (CA)
Title: A method of producing transgenic corn plants from callus of corn embryos
Inventor: AKULA ANISHA
IPC: C12N5/10
Filed: 2007-08-31
Abstract: A method for producing a transformable and embryogenic corn cell culture comprising: a) obtaining a Type II callus from corn embryos; b) initiating a cell suspension culture from cells of the callus; and c) culturing the cell suspension for about 5 days to 30 days in a liquid medium to produce the cell culture, wherein the cell culture is transferred to fresh growth media every 2-3 days; and wherein undesirable cell types are removed from the cell culture during transfer to fresh growth media.
Patent CA-2887792-A1 (CA)
Inventor: HITKO DONALD A
IPC: H03M1/66
Filed: 2015-04-10
Abstract: Disclosed herein is an apparatus for radio frequency digital-to-analog conversion of in-phase and quadrature bit streams. The apparatus may include a plurality of in-phase multiplying cells that receive an in-phase local oscillator signal and a plurality of in-phase bits, a plurality of quadrature multiplying cells that receive a quadrature local oscillator signal and a plurality of quadrature bits, a first output line connected to a first set of the plurality of in-phase multiplying cells and a first set of the plurality of quadrature multiplying cells, and a second output line connected to a second set of the plurality of in-phase multiplying cells and a second set of the plurality of quadrature multiplying cells. Each multiplying cell produces an output signal based on a received input bit. The output signals from each multiplying cell combine in phase on the connected output line.
Patent CA-2889011-A1 (CA)
Inventor: SILVA RENATA MOISES IWAMIZU
IPC: A41F9/02
Filed: 2013-10-22
Abstract: A belt that is self-adjustable to the waist comprises a long flexible strap (1), which constitutes the belt itself, with a cross-section formed by a complete flattened loop with a free gap (2), like a flattened tube, one of the ends of the strap being folded (3) and normally receiving at least one belt loop (4) and a conventional coupling device (5) suitable for providing means for quickly adjusting and coupling or uncoupling the other end of the strap (1); the strap (1) is split into two parts near the fold (3), forming two adjacent ends (6) and (7), inside which an elastic element (8) and a guide tongue (9) operate and together allow a variable belt diameter to be achieved after the belt is adjusted to the user's body. This effect can also be obtained with other arrangements, i.e. coupling the buckle (5) to other elastic means (11), (25) and (26), which also cooperate such that the belt (1), after being adjusted to the user's waist, can be automatically adjusted, the circumference of the belt increasing or decreasing sufficiently to provide the comfort desired when the user changes position, mainly when sitting down and standing up again, eliminating the uncomfortable sensation of a tight belt.
Patent CA-2889094-A1 (CA)
Title: System and method for tracking consumption habits of venue products
Inventor: FREDETTE BENOIT
IPC: G06Q30/02
Filed: 2013-10-23
Abstract: There is provided a system and method for tracking consumption of at least one product offered by a venue service. An event signal comprising event data indicative of an event occurring at the venue is received. A request signal comprising request data indicative of a request for the at least one product is received, the request made during occurrence of the event. The request data is then correlated with the event data to determine at least one activity related to the event and corresponding to the request. A relationship between the at least one activity and the request is established and a control signal indicative of the established relationship is output.
Patent CA-2891589-A1 (CA)
Title: Combinaison d'actionneur de piston et diaphragme
Inventor: ADAMS KEITH M
IPC: F16K31/126
Filed: 2013-10-31
Abstract: L'invention concerne un actionneur permettant d'activer une vanne linéaire telle qu'un robinet-vanne, l'actionneur comprenant une plaque d'étanchéité qui s'étend dans le diamètre d'un corps. Un diaphragme est placé sur la plaque et est totalement soutenu par celle-ci. Lorsqu'un milieu de pression pousse le diaphragme et la plaque d'étanchéité vers le bas, la plaque d'étanchéité pousse une tige vers le bas afin d'actionner une vanne. Un moyeu et une plaque de support annulaire peuvent être assemblés de façon à former la plaque, et la plaque peut avoir différentes tailles par sélection de plaques de support annulaires de différentes tailles.
Patent CA-2892682-A1 (CA)
Inventor: SINHA NEELIMA
IPC: A61K31/4025
Filed: 2014-03-12
Abstract: Disclosed are compounds of the Formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and m are as described herein, as modulators of the nicotinic acetylcholine receptors, particularly the a7 subtype, their tautomeric forms, stereoisomers, and their pharmaceutically acceptable salts, pharmaceutical compositions thereof, and combinations thereof with suitable other medicaments. Also disclosed are a process of preparation of the compounds and the intended uses thereof in therapy, particularly in the prophylaxis and/or treatment of disorders such as Alzheimer's disease, mild cognitive impairment, and senile dementia.
Patent CA-2897428-A1 (CA)
Inventor: REDDY SATISH
IPC: B01D53/78
Filed: 2013-01-09
Abstract: Systems and methods for reducing the energy requirements for carbon dioxide capture are described. Heat from system processes, such as steam condensation and hot flue gas, is utilized to heat reflux liquid utilized in release of carbon dioxide from absorbent solvent.
Patent CA-2897456-A1 (CA)
Inventor: LYNN TIMOTHY R
IPC: C07F7/00
Filed: 2013-11-20
Abstract: Methods for producing catalyst systems with increased productivity are disclosed. The methods may comprise providing a catalyst composition comprising a solvent and a single-site catalyst component, heating an inert gas to a temperature in a range of from about 100°C to about 150°C, and spray drying the catalyst composition in the presence of the inert gas to form a spray-dried catalyst system. Additionally, the methods may comprise providing a catalyst composition comprising a solvent, an activator, a filler material, a metallocene catalyst, and a Group 15 -containing catalyst; heating an inert gas to a temperature in a range of from about 100°C to about 150°C; and spray drying the catalyst composition in the presence of the inert gas to form a spray-dried catalyst system.
Patent CA-2897585-A1 (CA)
Inventor: KAISER FLORIAN
IPC: C07D401/04
Filed: 2014-02-20
Abstract: Compounds of formula (I) wherein R1, R2, R3, R4,R5, R6a and R6b are as as defined in the description; or a stereoisomer, salt, tautomer or N-oxide, or a polymorphic crystalline form, a co-crystal or a solvate of a compound or a stereoisomer, salt, tautomer or N-oxide thereof and their use as insecticides.
Patent CA-2901743-A1 (CA)
Title: Benzothiomorpholine and benzomorpholine derivatives as biofilm inhibitors
Inventor: LININGTON ROGER
IPC: A61P31/04
Filed: 2014-02-19
Abstract: Novel compounds and the novel use a class of previously identified small molecules for the inhibition of biofilm formation. Inhibition of biofilm formation can play a very important role in contributing to pathogenicity. Bacteria in the biofilm state have been shown to be 10-10,000-fold less susceptible to antibiotic treatment. Estimations made by the Centers for Disease Control (CDC) and the National Institutes of Health (NIH) attribute 65% to 80% of human infections as biofilm mediated. Consequently, biofilm formation is often responsible for chronic infections due to bacterial persistence despite antibiotic treatment.
Patent CA-2901873-A1 (CA)
Inventor: HWANG SANG YOUN
IPC: C07K14/62
Filed: 2014-02-26
Abstract: The present invention relates to: an insulin analog, wherein the insulin titer is reduced compared with a natural form and the binding force to an insulin receptor is reduced in order to increase the half-life of insulin in the blood; a conjugate, wherein the insulin analog and a carrier are connected; an extended release preparation containing the conjugate; and a method for preparing the conjugate.
Patent CA-2902362-A1 (CA)
Inventor: KNOLLE PERCY
IPC: A61K39/39
Filed: 2014-02-25
Abstract: In a first aspect, the present invention relates to the use of a TLR 9 agonist and/or a TLR 4 agonist in a prophylactic or therapeutic vaccine. According to the present vaccination strategy, the TLR 9 agonist and/or TLR 4 agonist is adapted or designed for use as a multiplying jump agent to enhance numbers and functionality of CD8 T cells in a prime-jump vaccination strategy for jump T cell expansion. In particular, the TLR 9 agonist and/or TLR 4 agonist is used as a component to be administered after priming of the individual to be vaccinated. The vaccination strategy is particularly useful against acute and chronic infections with intracellular pathogens or for anti-tumor vaccination. In another aspect, the present invention relates to a kit of part containing a prime agent and a multiplying jump agent according to the present invention.